In AD research, the APP/PS1 transgenic mouse model has demonstrated that PA intervention upregulates the BDNF/tropomyosin receptor kinase B (TrkB) signaling pathway and inhibits the activation of nuclear factor-κB (NF-κB). This evidence concerns the gene APP and Alzheimer disease.